RadioMedix
St. Louis, United States· Est.
RadioMedix develops targeted radiopharmaceuticals for diagnosing and treating cancer, focusing on rare neuroendocrine tumors.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $40M
About
RadioMedix develops targeted radiopharmaceuticals for diagnosing and treating cancer, focusing on rare neuroendocrine tumors.
OncologyRare Disease
Funding History
1Total raised:$40M
Venture$40M